Discussing Real-World Experience of Successes, Failures and Challenges: De‑Risking CMC for Bispecific & Multispecific Antibodies Through Early Developability‑Led Design
Discussing Real-World Experience of Successes, Failures and Challenges: De‑Risking CMC for Bispecific & Multispecific Antibodies Through Early Developability‑Led Design
